Department of Phoniatrics, ENT University Hospital Graz, Medical University Graz, Auenbruggerplatz 26-28, 8036, Graz, Austria.
Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, Medical University Graz, Graz, Austria.
Eur Arch Otorhinolaryngol. 2011 Aug;268(8):1201-1204. doi: 10.1007/s00405-010-1481-y. Epub 2011 Jan 8.
Considerable clinical and experimental data suggest that vitamin D plays a role in pathogenesis and progression of cancer; nevertheless clinical data for head and neck squamous cell carcinoma (HNSCC) are not available. The aim of our study was to associate tumor and clinical characteristics with status of vitamin D [25-hydroxyvitamin D (25(OH)D)]. 88 patients with newly diagnosed squamous cell carcinoma of the head and neck were included in the study. A blood draw was taken at the time of diagnosis. The observation period lasted from 2006 until 2010.
When compared to a cohort from an epidemiological study, serum levels of 25(OH)D were significantly reduced in patients with HNSCC. We furthermore found disease-free survival, as well as overall survival times to be significantly associated with 25(OH)D levels. In conclusion, results from our study suggest an influence of vitamin D status on cancer incidence, as well as on mortality of HNSCC.
大量临床和实验数据表明维生素 D 在癌症的发病机制和进展中起作用;然而,头颈部鳞状细胞癌(HNSCC)的临床数据尚不可用。我们研究的目的是将肿瘤和临床特征与维生素 D 状态[25-羟维生素 D(25(OH)D)]联系起来。88 例新诊断为头颈部鳞状细胞癌的患者纳入研究。在诊断时抽取血液样本。观察期从 2006 年持续到 2010 年。
与来自流行病学研究的队列相比,HNSCC 患者的血清 25(OH)D 水平显著降低。我们还发现无病生存期和总生存期与 25(OH)D 水平显著相关。总之,我们的研究结果表明维生素 D 状态对头颈部鳞状细胞癌的发病率和死亡率有影响。